Omega Therapeutics
David Berry joined Flagship Pioneering in 2005 where he is a general partner, focusing on conceiving, creating, resourcing, and launching groundbreaking companies. Dr. Berry has co-founded more than 20 companies across life sciences and sustainability, including Joule, Seres Therapeutics (NASDAQ: MCRB), T2 Biosystems (NASDAQ: TTOO), Indigo Agriculture, Evelo Biosciences, Eleven Biotherapeutics (NASDAQ: EBIO), LS9 (acquired by Renewable Energy Group), Axcella Health and Inari Agriculture. He has served as founding CEO of more than 10 companies, including Seres, Evelo and Axcella.
Dr. Berry received his M.D. from Harvard Medical School and his Ph.D. from MIT in biological engineering.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Omega Therapeutics
3 followers
Omega Therapeutics is a privately held, development-stage biotechnology company pioneering a new class of DNA-sequence-targeting, mRNA-encoded therapeutics to transform human medicine.